NYSE:PBHPharmaceuticals
How Lower Results and New Guidance at Prestige Consumer Healthcare (PBH) May Shift Its Investment Outlook
On August 7, 2025, Prestige Consumer Healthcare reported lower first quarter results year-over-year, revised its fiscal 2026 guidance downward, and reiterated an active pursuit of M&A opportunities, signaling a more cautious outlook for the near term.
Despite the lower guidance, company management highlighted approximately US$1 billion in projected free cash flow over the next four years, pointing to significant capital that could be used for acquisitions or other value-creating actions.
To...